Innoviva公司宣布达成一项协议,将在选定的国际市场扩大其药物Xacduro用于治疗鲍曼不动杆菌感染的可及性。该协议旨在让更多患者能够获得这一针对特定细菌感染的药物。
Innoviva公司宣布达成一项协议,将在选定的国际市场扩大其药物Xacduro用于治疗鲍曼不动杆菌感染的可及性。该协议旨在让更多患者能够获得这一针对特定细菌感染的药物。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.